Biotech VC Funds

Bain Capital Double Impact is the impact investing arm of Bain Capital, focusing on companies that generate strong financial returns while also delivering measurable social and environmental impact. The firm primarily invests in three core areas: Health and Wellness, Education and Workforce Development, and Sustainability. They target companies that are poised to make a significant impact in these fields, such as improving access to affordable healthcare, advancing educational opportunities, and promoting sustainable business practices. Their approach involves proactive sourcing of opportunities, deep due diligence on both the financial and impact potential of investments, and active partnership with portfolio companies to drive growth and impact. Bain Capital Double Impact is committed to long-term value creation, leveraging the broader Bain Capital platform to provide resources and expertise to their portfolio companies. Notable investments include companies like Cotopaxi, known for its sustainable outdoor gear, and Meteor Education, which supports transformative learning environments. The firm also emphasizes rigorous impact measurement and management, ensuring that their investments achieve sustained impact even at the exit stage.

Balderton Capital is a prominent venture capital firm based in London, specializing in early-stage investments across Europe. Established in 2000 as Benchmark Capital Europe, it became independent in 2007 and has since managed over $2.1 billion in funds. The firm focuses on backing technology and internet startups, and has invested in over 230 companies. Notable investments include Betfair, MySQL, Revolut, Depop, and THG (The Hut Group). These companies have achieved significant exits, with Betfair going public in 2010 and MySQL being acquired by Sun Microsystems in 2008. Balderton's current portfolio features innovative companies like GoCardless, ComplyAdvantage, and Darktrace. Balderton Capital operates both early-stage and growth funds, investing between $1 million and $20 million in Series A rounds and up to $50 million in growth stages. The firm has a sector-agnostic approach but typically invests in fintech, health tech, SaaS, and enterprise software. The leadership team includes partners like Bernard Liautaud and Rana Yared, who bring extensive experience and strategic insights. Balderton also offers robust support to its portfolio companies through its "Build with Balderton" platform, which provides resources in talent, marketing, finance, and legal services. Startups looking to partner with Balderton should highlight their potential for significant impact and scalability. The firm values detailed pitches and prefers to be approached through its network​.

Baltic Sandbox Ventures is a Vilnius-based venture capital firm focused on early-stage investments in deep tech and life sciences startups. Founded in 2018, the firm aims to nurture and develop the Baltic region’s ecosystem by backing R&D-driven startups that tackle complex technical challenges with potential for large-scale commercial applications. Their investments span across sectors like AI, biotechnology, cybersecurity, and precision medicine, supporting both software and hardware innovations. With a portfolio of over 23 investments, including companies like Black Swan Space and Biohifas, Baltic Sandbox Ventures typically co-invests with angel investors and other venture funds. The firm offers a range of support through incubation and acceleration programs, providing up to €400,000 in funding to promising startups. Their unique approach involves working closely with scientific founders, ensuring that they have the right team and intellectual property protections in place. Led by general partners Sandra Golbreich, Andrius Milinavičius, and Erik Bhullar, Baltic Sandbox Ventures has positioned itself as one of the most active early-stage investors in the Baltic region, helping to bridge the gap between research and commercial viability​.

BAM Ventures, based in Los Angeles, is an early-stage venture capital firm co-founded by Brian Lee, known for his successful ventures such as LegalZoom, ShoeDazzle, and The Honest Company. The firm focuses on consumer-centric startups, leveraging their deep operational experience and extensive network to support ambitious founders. BAM Ventures has a diverse portfolio that includes notable companies like The Honest Company, Honey, Tala, Wondery, and Scopely. They have successfully exited several investments, including Outdoor Voices, ClassPass, and fuboTV. BAM Ventures is committed to investing in innovative companies that disrupt the status quo and resonate deeply with consumers. The firm primarily invests in early-stage companies, providing not only capital but also hands-on support, mentorship, and access to their network. They are particularly passionate about the Los Angeles startup ecosystem, seeing it as a natural hub for consumer-focused businesses.

Bankinter VC (Bankinter Capital Riesgo) is the corporate venture capital arm of Bankinter, one of Spain's leading publicly traded banks, based in Madrid. Founded in 2001 and investing actively through its Fundación Innovación Bankinter startup program since 2013, the venture unit manages multiple venture capital funds with total assets exceeding €2.3 billion, including vehicles such as Helia III, Helia IV, MVB, and Rhea. Checks typically range from $1 million to $10 million across seed through Series B stages. Bankinter Investment has backed 40-plus startups across fintech, software, health technology, biotech, SaaS, data analytics, and food sectors. Notable portfolio companies include Carto in location intelligence, Flywire in global payments (which completed an IPO), and Jobandtalent in staffing platforms. The fund adds value by sharing experiences, best practices, and access to Bankinter's corporate resources and industry relationships with portfolio companies, particularly those targeting financial services customers. Bankinter is known within the Spanish banking sector as an innovation-forward institution, making its CVC arm a natural fit for identifying fintech and digital transformation opportunities ahead of the broader market. Portfolio companies benefit from the bank's institutional credibility, client relationships, and potential for commercial partnership or distribution through Bankinter's business banking and investment management channels. The combination of patient institutional capital, a long operating history, and a €2.3 billion fund platform distinguishes Bankinter VC as one of the more substantive corporate venture programs in Southern Europe.

Bantam Group is a venture capital firm and advisory service based near Boston, Massachusetts. Founded by Joe Caruso, the firm emphasizes deep, personal relationships with entrepreneurs and provides a range of support including investment, strategic advice, and hands-on management. Bantam Group's investment focus spans various industries such as software, web services, materials/semiconductors, energy, security, analytical instrumentation, business services, life sciences, and retail/consumer sectors. They are particularly drawn to novel and big ideas, as well as simple concepts executed with passion. Notable investments include HubSpot, Constant Contact, Acquia, and Crashlytics. The firm's geographic focus is primarily on the greater Boston area, preferring to work closely with founders they can meet in person or where there are existing relationships with board members or other investors. Bantam Group has a flexible approach, considering unproven technologies and investing in both stable and troubled situations, with transaction sizes ranging from $10,000 to several million dollars. For entrepreneurs looking to engage with Bantam Group, it is essential to demonstrate high integrity and candid communication. They seek relationships defined by mutual respect and rapport, often going beyond typical investor roles to serve as mentors, coaches, and advocates for their portfolio companies.

Baruch Future Ventures (BFV) is a San Francisco-based venture capital firm dedicated to investing in early-stage companies that focus on climate technology and resource management. Founded by Tom Baruch, a veteran investor with over three decades of experience, BFV leverages its deep industry expertise to support innovations that address critical global challenges, particularly in resource-scarce and climate-sensitive markets. BFV’s investment strategy centers around companies that are pioneering solutions in climate restoration, resource scarcity, and sustainability. The firm’s portfolio includes companies that are transforming power infrastructures, supply chains, and materials manufacturing. Notable investments include partnerships with Breakthrough Energy Ventures, founded by Bill Gates, in companies like Aeroseal and Fervo Energy. Tom Baruch, the founder of BFV, has a storied career in venture capital, including founding CMEA Capital and Formation 8, which were instrumental in launching multiple successful companies, including 10 that achieved unicorn status. BFV prides itself on its ability to identify and scale innovative technologies that can lead to significant environmental and economic impacts. With a strong track record of generating returns and fostering groundbreaking companies, BFV remains a key player in advancing the climate economy through strategic investments in innovative and sustainable technologies.

BASF Venture Capital GmbH (BVC) is the corporate venture arm of BASF, focused on investing in early to mid-stage companies that align with the group's strategic priorities. Established in 2001, BVC targets innovative sectors including decarbonization, circular economy, agricultural technology (AgTech), new materials, digitization, and disruptive business models. Its global presence spans key hubs like Mannheim, Toronto, Boston, Los Angeles, Shanghai, and Sao Paulo, enabling it to connect startups with BASF's extensive network of research, partners, and clients worldwide. BVC manages an evergreen fund of approximately €250 million, which allows for flexibility in investment timelines. Typically, it engages in seed to Series B rounds, emphasizing strategic alignment with BASF’s core business areas. The venture team collaborates closely with portfolio companies, providing not only financial backing but also access to BASF's industry expertise and resources, helping startups scale and penetrate new markets. The firm's portfolio includes diverse ventures such as IntelliSense.io (AI for industrial efficiency), Computomics (predictive breeding in agriculture), and Essentium (industrial 3D printing). Additionally, BVC has invested in various technology funds, including partnerships with accelerators like Alchemist to stay connected with emerging trends and innovations. Led by a team of seasoned professionals across multiple continents, BVC's approach focuses on fostering innovation that contributes to sustainability and future-ready solutions for the chemical and broader industrial sectors.

Basis Set Ventures, founded in 2017 and headquartered in Menlo Park, California, is a venture capital firm that focuses on early-stage investments in artificial intelligence and automation. The firm aims to invest in companies that transform how people work, focusing on scalable infrastructure, intelligent collaboration, automated workflows, and autonomous machines. Their diverse portfolio includes companies like Assembled, a workforce management platform; Ergeon, which leads in outdoor home construction through its tech platform; and Path Robotics, known for autonomous welding robots. Other notable investments are Quince, a company democratizing luxury goods, and Trendsi, which automates supply chain management for modern commerce businesses. Basis Set Ventures emphasizes supporting companies from seed stages, typically writing checks between $1 million and $3 million. They provide more than just financial backing, leveraging their extensive network and deep expertise to help their portfolio companies scale effectively.

Batterson Venture Capital (BVC), now operating as VCapital, is a Chicago-based venture capital firm founded in 1995 by Len Batterson. The firm targets entrepreneurial seed, startup, and early-stage companies needing $500,000 to $5 million — deliberately filling what Batterson identified as the widely neglected funding gap that at the time received only 6% of all venture capital. Batterson previously founded Batterson, Johnson & Wang, the first Chicago-based early-stage technology and medical institutional VC fund, establishing his reputation as a pioneer of Midwest venture investing. The firm has backed 29 companies across software, health technology, clean technology, media, biotech, edtech, and data analytics. Notable exits include Cleversafe, acquired by IBM for $1.3 billion; Cybersource, acquired by Visa; Health Magazine, acquired by AOL/Time Warner; and Padcaster. Other portfolio companies include Beyond.com, Allscripts, and Illinois Superconductor Corporation. Checks average $1.5 million and range up to $5 million at pre-seed through Series A stages, with a focus on US companies and the Midwest in particular. Batterson Venture Capital's legacy is its role in establishing early-stage institutional venture capital in Chicago and the broader Midwest at a time when the region was largely bypassed by coastal funds. Len Batterson's successive firms — spanning three decades of early-stage investing — helped build the infrastructure, track record, and investor confidence that enabled the Chicago tech ecosystem to mature. The firm's continued operation as VCapital reflects the durability of its founding thesis: that underserved early-stage companies in non-coastal markets represent a genuine and repeatable investment opportunity.

Baxter Ventures is the corporate venture capital arm of Baxter International Inc., a global medical technology company with over 85 years of healthcare innovation history. Founded in 2011 and based in Deerfield, Illinois, the firm invests in companies developing innovative technologies, products, and therapies that advance patient care. Investment areas encompass therapeutic applications complementary to Baxter's presence in critical care, hospital care, nutritional care, renal care, and surgical care, as well as cutting-edge technologies outside the parent's existing product portfolio. The firm targets Series A through later-stage rounds, typically writing checks between $3 million and $25 million, and has made 30 investments across health technology, biotech, pharma, hardware, and software. Portfolio companies include VitalConnect (wearable biosensors), Hospital IQ (hospital operations platform), Medasense (pain monitoring), Covagen (biopharmaceuticals, acquired by Johnson & Johnson), SANIFIT (calcification therapeutics), and ProMedix. Each investment undergoes rigorous evaluation for its potential to address unmet clinical needs and deliver long-term sustainable growth. Baxter Ventures supports founders by connecting them to Baxter International's global distribution channels, clinical development expertise, and commercial infrastructure. Backed by a parent company with approximately $15 billion in annual revenues, portfolio companies gain access to a uniquely scaled corporate partner capable of accelerating market adoption in hospital and clinical settings across the United States and Europe.

Bayern Kapital, founded in 1995 and based in Landshut, Germany, is a key venture capital firm focused on supporting high-tech startups and scale-ups in Bavaria. With nearly 30 years of experience, the firm manages around €700 million and has invested in over 320 Bavarian high-tech companies. Bayern Kapital offers investments ranging from €250,000 to €25 million per company, targeting sectors such as biotechnology, medical technology, software and IT, environmental technology, and new materials. The firm's investment approach emphasizes long-term partnerships, acting as a co-investor alongside private investors to support startups through various growth phases from seed to scale-up. Bayern Kapital prides itself on fostering innovation and entrepreneurship in Bavaria, aiming to drive job creation and economic development in the region. Some notable investments in their portfolio include companies like ProGlove, Immunic Therapeutics, and Sphera. Bayern Kapital's strategy is to offer not just financial support but also leverage their extensive network to help startups connect with potential investors, partners, and customers, thereby enhancing their growth prospects. Key team members include Wolfgang Härtl, Investment Director, who leads their dedicated team of over 40 professionals with diverse academic and professional backgrounds, contributing to their robust support system for portfolio companies​.

BBG Ventures is a New York-based venture capital fund that focuses on early-stage investments in women-led technology companies. The firm, which evolved from AOL's #BUILTBYGIRLS initiative, aims to support and inspire women and girls in the tech economy. BBG Ventures was founded in 2014 and is committed to backing diverse founders who are creating consumer applications and services that make lives simpler, better, and more enjoyable​. BBG Ventures targets sectors such as consumer technology, FinTech, and healthcare, with typical investments ranging from $500,000 to $1 million. They lead or co-lead Seed and Pre-Seed rounds, supporting founders who have a deep, intuitive understanding of the problems they aim to solve​. Notable investments include companies like Zola, Modsy, Spring Health, Blueland, Lola, Starface, and Pymetrics. The fund is led by a team dedicated to fostering innovation and supporting underrepresented entrepreneurs. They provide more than just capital, offering strategic guidance and leveraging their extensive network to help founders succeed​.

The Thrive Venture Fund is the direct-investment vehicle within BDC Capital's Thrive Platform for Women, a $500M investment platform launched in 2022 and described as the largest of its kind in the world, created to close the equity gap faced by women-led companies in Canada. The platform comprises the $300M Thrive Venture Fund, a $100M indirect investment envelope that backs other funds, and the $100M Thrive Lab for equity and equity-like investments in women-led social-impact businesses. Operated by BDC, the Business Development Bank of Canada, the Thrive Venture Fund makes direct equity investments in women-led Canadian technology companies at the seed and Series A and B stages, remaining sector agnostic while targeting businesses with strong growth and scalable market potential, and it is willing to lead. It builds on the firm's pioneering Women in Technology (WIT) Venture Fund, which made 38 investments and recorded successful exits including Beanworks, Kira Talent, Unsplash and Nudge. The fund is led by Managing Partner Mona Minhas, who succeeded long-time women's-fund leader Michelle Scarborough, with partners Steven Abrams, Thomas Green and Kimberly Yeung. Portfolio companies span AI, biotech, health, robotics and consumer sectors and include Waabi in autonomous driving, Sanctuary AI in humanoid robotics, SRTX/Sheertex in advanced textiles, Bridgit in construction tech, Eli Health, Private AI, Omy Laboratoires, Congruence Therapeutics, Radiant Biotherapeutics and Puzzle Medical. By dedicating significant institutional capital to women-led companies, the Thrive Venture Fund works to close Canada's gender-equity gap in venture funding.

BDMI (Bertelsmann Digital Media Investments) is the venture capital arm of Bertelsmann, based in New York City. The firm focuses on early-stage investments, managing both a seed fund and a traditional early-stage fund. BDMI typically invests between $500,000 to $5 million in sectors such as B2B, fintech, consumer, and media. For their seed fund, BDMI looks for products or services that are already live in the marketplace with early signs of product-market fit. They generally do not lead seed stage investments but prefer to join syndicates with a lead investor already in place. This strategy allows them to leverage the expertise of lead investors while providing crucial early-stage funding. BDMI’s notable investments include companies like Fatherly, Suzy, Inverse, DramaFever, Food52, and BarkBox. These investments reflect the firm’s commitment to backing innovative companies that are disrupting their respective industries. BDMI’s connection to Bertelsmann provides their portfolio companies with access to a vast network of resources and industry expertise, helping them scale and succeed in competitive markets. The firm prides itself on supporting its portfolio companies beyond just financial investment. By leveraging Bertelsmann's extensive network and resources, BDMI offers strategic guidance and operational support, helping startups navigate challenges and achieve their growth objectives. This holistic approach to venture capital makes BDMI a valuable partner for startups looking to make a significant impact in the digital media landscape.

BeAble Capital, established in 2016 and headquartered in Madrid, Spain, focuses on early-stage investments in deep science and industrial technologies. Their primary mission is to advance technologies from academic and research institutions into market-ready products, aligning with the United Nations Sustainable Development Goals. BeAble Capital's investment sectors include New Space, New Energy, New Materials, Agro & Food, Environment, Healthcare & Wellbeing, Medtech, Robotics, and AI. Notable investments in their portfolio include companies like Alen Space, which develops small satellites, and A4Cell, which specializes in single-cell monitoring tools. Another significant investment is in Alcyon Photonics, a firm that designs and manufactures photonic integrated circuits. BeAble Capital is led by founders Almudena Trigo, David López, and other partners. They emphasize a hands-on approach in the early development stages, including proof of concept, scale-up, and pre-industrial phases, providing critical support to transform scientific discoveries into commercially viable products. Their strategy involves close collaboration with universities, research centers, and industrial companies to identify promising projects, focusing on technologies that address unmet needs in high-growth markets. The firm has made over 50 investments, reflecting its commitment to fostering innovation and industrial growth in Spain and beyond.

Beast Ventures is a venture capital firm based in London, focusing on early-stage investments in deep tech and transformative technologies. Established in 2015, Beast Ventures targets startups across the UK and Continental Europe that are working on breakthrough engineering, applied science, and technology (hence the acronym BEAST). The firm emphasizes investments in frontier technologies that hold the potential for significant impact in areas such as health, climate, and society. Beast Ventures typically invests at the seed stage, providing support to founders from the inception of their companies through various stages of growth. The firm’s investment portfolio spans diverse industries including artificial intelligence, biotech, cybersecurity, climate tech, and more. Notable investments include companies like Ochre Bio, which focuses on developing RNA therapies for liver disease, and Nutropy, a biotech startup creating sustainable food products. The fund's investment strategy is geared towards achieving outsized returns by backing startups that push the boundaries of science and technology, particularly those with the potential to create significant societal impact. Beast Ventures offers flexible investment sizes, ranging from $100,000 to $2 million, and is known for its deep commitment to supporting cutting-edge innovation​.

Bee Partners, founded in 2009, is a pre-seed venture capital firm based in San Francisco. The firm focuses on investing in deep tech startups that are at the forefront of human-machine convergence. Their primary areas of investment are Human-Machine Interaction, Machine-to-Machine Learning, and Biological Machines. Notable portfolio companies include Rapid Robotics, which develops AI-powered robots for industrial automation, and InnerPlant, a company that provides plant-based bio-signals for agricultural efficiency. Other significant investments are in companies like Embroker, a commercial insurance platform, and New Culture, which produces animal-free dairy products​​. Bee Partners has been instrumental in supporting innovative startups through early investments and strategic guidance. They have a strong track record of helping their portfolio companies secure follow-on funding from leading venture capital firms​.

Benchmark Capital is a premier venture capital firm known for its early-stage investments in transformative companies. Notable investments include eBay, Twitter, Uber, Instagram, and Snapchat, showcasing their knack for identifying high-potential startups. They focus on sectors such as social media, mobile technology, cloud computing, and enterprise software, typically investing at the seed and Series A stages. Benchmark primarily operates within the United States, with offices in San Francisco and Menlo Park. Their investment strategy emphasizes hands-on support and close collaboration with entrepreneurs, aiming to drive startups to achieve market leadership. The firm is known for its unique equal partnership model, ensuring that all partners have an equal say in decision-making processes. With an average check size varying from $1 million to $20 million, Benchmark often leads investment rounds, bringing significant value through strategic guidance and robust industry networks. Founders looking to engage with Benchmark should be prepared with a strong vision and the ability to demonstrate potential for large-scale impact. The firm is led by a team of seasoned investors, including partners like Peter Fenton, Bill Gurley, and Sarah Tavel, who bring extensive experience and a track record of successful exits. This powerhouse team leverages their expertise to provide unparalleled support to their portfolio companies, driving innovation and growth across various industries​.

Beringea is a transatlantic venture capital firm with a significant presence in the UK and the US, managing over $900 million in assets. Founded in 1988, Beringea has made a name for itself by investing in high-growth companies across sectors such as healthcare, clean technology, media, consumer services, SaaS, and technology. Notable investments from Beringea include successful exits like D3O, ContactEngine, and Inskin Media, showcasing their ability to nurture and grow impactful businesses. Their portfolio also features promising companies like MPB, Flywheel, Asterra, Moonshot, and Akadeum, which highlight their focus on innovation and scalability. Beringea’s investment strategy involves early and growth-stage funding, with typical investments ranging from $2 million to $10 million. They emphasize scalable business models targeting large markets and have a strong track record of leading funding rounds and providing significant operational support to their portfolio companies. Geographically, Beringea operates out of Farmington Hills, Michigan, and London, with additional offices and operations supporting their global reach. The firm's team includes experienced partners like Michael Gross and Stuart Veale, who bring extensive industry knowledge and leadership to the table.

Berkeley SkyDeck is UC Berkeley's premier startup accelerator, integrating the extensive resources of one of the world's top universities with a robust venture fund. Launched as a partnership between the Haas School of Business, the College of Engineering, and the Office of the Vice Chancellor for Research, SkyDeck combines traditional accelerator consulting with academic expertise and research resources​. The Berkeley SkyDeck Fund, with $85 million under management, invests in startups participating in the accelerator program and those with Berkeley affiliations. Each startup in the accelerator receives an initial investment of $200,000. The fund is known for its high activity, making over 100 investments in just three years, backed by prominent VCs like Sequoia Capital and Mayfield Fund. SkyDeck provides startups with access to a vast network of advisors, industry partners, and UC Berkeley alumni, helping them with sales, hiring, and further financing introductions. This network-driven approach has proven successful for alumni startups like DeepScribe and SuperAnnotate, which have raised significant funds and achieved substantial growth. The accelerator supports a diverse range of startups from various sectors and stages, including biotech, hardware, consumer products, and enterprise solutions. SkyDeck also emphasizes diversity, equity, and inclusion, actively working to support underrepresented founders.

Bessemer Venture Partners (BVP), headquartered in San Francisco, is one of the oldest venture capital firms in the United States. Established in 1911, BVP has a long history of investing in early- and growth-stage companies across various industries, including technology, healthcare, and consumer sectors. Some of their notable investments include Shopify, LinkedIn, DocuSign, Pinterest, and Yelp​. BVP is known for its systematic approach to venture capital, leveraging deep industry insights and a decentralized decision-making process. This allows individual partners significant autonomy to invest across different stages, industries, and geographies. The firm has offices not only in the U.S. but also in India, Israel, and the UK​. BVP has raised multiple funds over the years, including a $3.85 billion early-stage fund in 2021 and a $780 million buyout fund under BVP Forge in 2022. These funds reflect their strategy of supporting startups from inception through to growth and eventual exit​ . Their "Anti-Portfolio" is a unique feature on their website, showcasing major investment opportunities they missed, including companies like Apple and eBay, highlighting their commitment to transparency and learning from past decisions​ ​. With a focus on fostering innovation and supporting dynamic founders, Bessemer Venture Partners continues to be a significant player in the global venture capital landscape.

Betaworks is a product-focused, seed-stage venture capital firm based in New York City and San Francisco. Founded by John Borthwick, the firm invests in pre-seed and seed-stage startups, typically with check sizes ranging from $250,000 to $750,000. Betaworks is known for its thematic approach, immersing itself in emerging technologies and user behaviors to identify and nurture high-potential startups. Betaworks has built and invested in notable companies such as Giphy, Dots, bitly, Tweetdeck, and Chartbeat. Their investments also include Twitter, Tumblr, Kickstarter, Medium, Hugging Face, and RecRoom. The firm operates Betaworks Camp, a cohort-based investment and product development program that delves into specific tech themes such as AI, gaming, and decentralization. The team at Betaworks includes John Borthwick, Jordan Crook, and Jonathan Chin, among others, who bring extensive experience in technology, media, and venture capital. Betaworks continues to foster innovation through its community-focused initiatives and strategic investments in the latest technological trends.

Better Ventures is a mission-driven VC firm investing in early-stage startups that harness cutting-edge technology to address pressing global challenges. Their notable investments include Meati, a sustainable protein innovator, and SMBX, a platform democratizing business financing. With a focus on sectors like climate tech, human health, and equitable economies, they back diverse teams aligned with the UN's Sustainable Development Goals. Based in Oakland, Better Ventures leads seed rounds, providing active support for founders committed to making a measurable impact. The team looks for companies that can scale profitably while driving social and environmental change, ensuring purpose and profit go hand-in-hand. Better Ventures prefers founders who blend technological innovation with a clear mission. They typically write checks of $500k to $1 million and often lead or co-lead rounds. The firm emphasizes strong partnerships, working closely with founders to scale their impact. Startups should approach Better Ventures with a well-defined purpose, as they prioritize purpose-driven innovation. The founding team includes Rick Moss and Jenny Kassan, both seasoned in impact investing and business development. Better Ventures' geographic focus spans the U.S., especially targeting hubs of innovation. Their approach to funding emphasizes scalability, sustainability, and measurable impact, creating value for both investors and society.

Beyond Next Ventures, founded in 2014 and based in Tokyo, focuses on early-stage investments in deep tech startups, primarily in Japan and India. The firm invests in various sectors including medtech, healthcare, biotechnology, agriculture, food, digital, space, and climate technology​. Notable investments include companies like MediBuddy, GigIndia, QD Laser, and Susmed. MediBuddy is a significant player in telemedicine and healthcare services in India, while QD Laser and Susmed are notable for their IPOs on the Tokyo Stock Exchange​. Beyond Next Ventures typically leads early-stage financing rounds, offering extensive support through their incubator programs aimed at commercializing advanced research. The firm has about $340 million under management, underscoring its commitment to fostering innovation in deep tech and science-based startups​. The leadership team, including CEO Tsuyoshi Ito and Managing Director Kengo Ueha, brings a wealth of experience and strategic insight, supporting startups through growth management, market entry, and expansion strategies.

Bharat Fund, also known as Bharat Innovation Fund, is a venture capital firm based in India that focuses on early-stage investments in deep-tech and IP-driven startups. Founded under the aegis of CIIE.CO at IIM Ahmedabad, the fund aims to support companies that provide innovative solutions in sectors such as healthcare, agriculture, renewable energy, and advanced technology. The fund typically invests in pre-Series A and Series A stages, providing not just capital but also strategic insights, market development support, and access to extensive networks to help startups scale effectively. Bharat Fund’s mission is to back transformative entrepreneurs who are addressing some of the toughest global challenges, with the goal of turning their ventures into globally competitive and disruptive companies. Bharat Fund’s portfolio includes startups that are leveraging technology to create significant impact. By remaining deeply engaged throughout the lifecycle of their investments, Bharat Fund aims to significantly de-risk the conversion of innovative ideas into successful companies. The fund’s name, "Bharat," is inspired by the traditional name for India and reflects their dedication to fostering breakthrough innovations from the country. Their approach combines a decade of early-stage investing experience with support from key partners like Tata Trusts, enabling them to build a robust platform for nurturing high-potential startups.

Big Idea Ventures, founded in 2018, is a leading venture capital firm focusing on the alternative protein and food technology sectors. With over 110 early-stage investments, they have become the most active investor in FoodTech globally. The firm operates through its New Protein Fund and Generation Food Rural Partners fund, supporting innovative companies in plant-based, cell-based, and fermentation-enabled food technologies. Notable investments include companies like Naturannova, which creates sustainable peptide-based flavors using AI, and SoundEats, a cultivated seafood pioneer. Other standout portfolio companies are New Wave Biotech, which develops bioprocess optimization software, and Loki Foods, which produces plant-based seafood using renewable energy in Iceland. Big Idea Ventures runs bi-annual accelerator programs in New York, Paris, and Singapore, providing selected companies with a $200,000 investment and access to an extensive network of partners and investors. This hands-on support helps startups navigate product development, scaling, and market entry. Led by founder Andrew D. Ive, Big Idea Ventures collaborates with strategic partners like Temasek Holdings, Tyson Ventures, and Givaudan, aiming to drive significant advancements in food security and sustainability.

Big Pi Ventures is a venture capital firm based in Greece, focusing on seed and early-stage investments, particularly in deep-tech and science-driven startups. Established with a vision to drive transformative innovation, Big Pi partners with exceptional teams developing technologies that address significant global challenges. Their investments span various sectors, including artificial intelligence, health and life sciences, and climate technology, often targeting companies with strong intellectual property or technological advantages. The firm is anchored in Greece but maintains a global perspective, requiring that its portfolio companies establish substantial operations in Greece. Notable investments include companies like TileDB, Orfium, and Navenio, reflecting their commitment to backing ventures that have the potential to scale internationally. Big Pi is led by a team of seasoned entrepreneurs and investors, including Marco Veremis, co-founder of Upstream, and Alex Eleftheriadis, a pioneer in video compression technology. The team offers more than just capital, providing strategic support in areas like product design, scaling, and global market expansion. Their latest rebranding and new fund, announced in 2023, signify their ongoing commitment to fostering innovation and supporting the next generation of tech leaders.

Binance Labs, the venture capital arm and accelerator of Binance, focuses on empowering the decentralized web through strategic investments in blockchain startups. Founded in 2018, Binance Labs has supported over 200 projects across more than 25 countries, with a portfolio that includes prominent names like Polygon, Perpetual Protocol, and Dune Analytics. The firm invests in early-stage companies that demonstrate strong product innovation, sustainable business models, significant traction, and robust technology. Their strategic approach includes equity stakes and token deals, emphasizing security, compliance, user conversion, and enhancing user experience across various regions. Geographically, Binance Labs has a global reach but places a significant focus on expanding blockchain infrastructure and Web3 applications. Recent investments include a substantial stake in Aptos Labs, aimed at developing a high-performance, production-ready layer-1 blockchain. Leading the venture is Yi He, Co-Founder of Binance, who oversees a $9 billion asset portfolio. Binance Labs supports founders through their Incubation Program, providing advisory services, operational support, and a strong network to help projects navigate the complex blockchain landscape. For startups interested in joining Binance Labs, they should demonstrate clear innovation, a viable business model, and a commitment to long-term growth in the blockchain ecosystem.

BioAdvance is a prominent life sciences venture capital fund based in the mid-Atlantic region, focusing on therapeutics, diagnostics, medical devices, research tools, and health IT. With over 100 investments, they have achieved 23 exits and brought 12 FDA-approved products to market. Their portfolio companies, such as Palvella Therapeutics and Strados Labs, have attracted significant follow-on funding, collectively raising over $4.2 billion. BioAdvance operates as an evergreen fund, enabling continuous reinvestment and long-term partnership with entrepreneurs. The fund emphasizes capital efficiency and works closely with startups to maximize limited resources. Their investment strategy centers on advancing human health technologies with potential for high impact, targeting early-stage companies with scalable innovations. Led by a team of seasoned executives, scientists, and physicians, BioAdvance is collaborative, often playing an active role in company growth and guiding entrepreneurs toward successful exits via IPOs or acquisitions. They prefer to engage with startups that have a strong business case and well-developed pitch, ensuring a strong fit with their mission of improving human health.

Bioeconomy Capital is a San Francisco and Seattle-based venture capital firm founded in 2015. The firm focuses on early-stage investments in biotechnology, life sciences, and sustainability technology. Bioeconomy Capital is driven by the goal of accelerating the biotechnology revolution by supporting companies that are developing critical infrastructure and innovative technologies for the 21st century. With a strong foundation in synthetic biology, Bioeconomy Capital leverages decades of expertise in life sciences and engineering to back startups with transformative potential. The firm’s portfolio includes notable companies such as Zymergen, Riffyn, Synthace, RoosterBio, and Arzeda. Bioeconomy Capital typically invests between $100K and $5M, with a sweet spot of $1.5M per investment. The firm has a global focus, primarily investing in the U.S. but occasionally supporting companies in the U.K. and other regions. Led by managing directors Rob Carlson and Rik Wehbring, Bioeconomy Capital plays a strategic role in helping its portfolio companies navigate the complexities of scaling biotech and sustainability solutions​.

BioGeneration Ventures (BGV) is a prominent venture capital firm based in Naarden, Netherlands, specializing in early-stage European biotech companies. With over €400 million under management, BGV focuses on sectors like biopharma, medtech, and diagnostics. Their portfolio features notable investments in companies such as AcertaPharma, argenx, and New Amsterdam Pharma, underscoring their success in advancing groundbreaking scientific innovations and addressing unmet medical needs. BGV typically engages in seed to early growth stages, strategically guiding companies through clinical trials and drug development to achieve substantial exits. Their rigorous selection process ensures they back ventures with the highest potential for impactful outcomes. BGV's investment philosophy centers on combining deep scientific expertise with commercial insight to build world-class biotech firms. The firm is led by a team of experienced professionals, including managing partners Edward van Wezel and Suzanne Morsink, who bring extensive backgrounds in life sciences and venture capital. They actively support portfolio companies with strategic guidance, leveraging their broad network and industry knowledge to drive growth and innovation. BGV is committed to fostering the next generation of biotech leaders, with a clear focus on creating value for both investors and society by addressing critical health challenges through cutting-edge science and technology

BioMedPartners, through its BioMedInvest funds, focuses on venture capital investments in early to mid-stage companies in the biotechnology, pharmaceutical, and medical technology sectors. Based in Basel, Switzerland, the firm supports innovations primarily in the Alpine region and other European markets. Notable portfolio companies include Aleva Neurotherapeutics, developing next-generation implants for deep brain stimulation; Anergis, which focuses on peptide-based immunotherapies for allergies; and Evolva, a biotech firm creating sustainable ingredients for health and nutrition. Additionally, BioMedPartners has invested in companies like Hookipa Biotech, which develops novel immunotherapies for infectious diseases and cancer, and Sequana Medical, specializing in implantable fluid management systems. The BioMedPartners team is led by General Partners such as Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive experience in drug development, finance, and technology. The firm takes an active role in the development of its portfolio companies, often leading investment rounds and participating as a syndicate partner​.

Bioqube Ventures is a specialist life sciences venture capital firm focused on early-stage investments in Europe, particularly in therapeutic assets and disruptive healthcare technologies. Founded in 2016 by Debora Dumont and Nico Vandervelpen, the firm launched its independent fund, Bioqube Factory Fund I, in 2020. This fund, which has secured over €60 million in its initial closing, aims to support the development of breakthrough therapies by leveraging Bioqube's unique dual investment model. This model includes both traditional venture investments and a "Create" strategy, which focuses on de-risking projects before establishing new ventures. The fund's strategy is deeply rooted in supporting high-potential scientific innovations, transforming them into commercially viable biotechnologies. Bioqube has strong partnerships with prominent investors like the European Investment Fund, Johnson & Johnson Innovation, and Genmab, further bolstering its ability to drive significant advancements in the life sciences sector. The Bioqube team is composed of experienced fund managers, sector experts, and serial entrepreneurs, bringing a hands-on approach to guiding portfolio companies through their growth stages. The firm has a significant presence in Europe, with a focus on regions such as the Benelux, France, and Germany, aiming to build a new generation of leading biotech companies.

BioRock Ventures is a Palo Alto, California-based seed-stage venture capital firm founded in 2019, dedicated to accelerating the development of novel medicines. The firm invests in early-stage biopharmaceutical companies developing novel FDA-regulated therapeutic drugs, covering all disease areas, development stages, and therapeutic modalities. BioRock operates two funds — BioRock Ventures I and Fund II — and leads rounds with checks up to $2 million at angel, seed, and Series A stages. The firm is led by Dr. Mary Wheeler, PhD, MBA, Founding Managing Partner, with over two decades of experience in the therapeutics startup sector. With 15 investments concentrated in biotech and pharma, BioRock's portfolio includes Immusoft (gene-modified B cell therapies for rare diseases), Primmune Therapeutics, and Veana Therapeutics — all working within drug discovery and early-stage clinical development. The firm focuses on companies addressing unmet medical needs with scientifically rigorous approaches, prioritizing therapeutic innovation over platform plays. BioRock Ventures leads its rounds, positioning itself as a conviction-driven, science-first investor at the earliest stages of biopharmaceutical company formation. Dr. Wheeler's deep operating background in therapeutics startups allows the firm to evaluate scientific merit with the rigor of an insider, not just a financial analyst. For founders navigating the early challenges of building biopharma companies — from IND-enabling studies through seed fundraising — BioRock provides both capital and an experienced scientific partner committed to the long development timelines that novel therapeutics require.

Bioverge is a venture capital firm and investment platform specializing in early-stage healthcare startups. Based in San Francisco, Bioverge provides accredited investors with opportunities to invest in innovative healthcare companies that aim to transform the industry. The platform leverages deep domain expertise and a robust network to offer exclusive access to premier healthcare startups, ensuring that investments have both high impact and the potential for significant returns. Bioverge Funds, such as the Bioverge Access Fund, allow investors to diversify their portfolios by investing in a curated selection of healthcare startups through a single investment. These funds provide preferred access to deals, discounted fees, and the benefit of spreading investment risk across multiple companies. Bioverge emphasizes a data-driven investment approach, utilizing AI to select the most promising opportunities in the healthcare sector. Notable investments by Bioverge include companies like Enveda, which focuses on developing next-generation small-molecule therapeutics, and JelikaLite, which has created a non-invasive therapy for children with autism. Bioverge's investment strategy aims to support startups that offer groundbreaking solutions in healthcare, biotechnology, and medical technology. The firm was founded by Neil Littman, who brings extensive experience in healthcare venture capital. Bioverge's mission is to democratize access to high-quality healthcare investments, providing individual investors with the same opportunities as institutional investors.

Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region​.

Black Bay Energy Capital is a New Orleans-based private equity firm that specializes in the energy sector, targeting North American companies. Established in 2016, it focuses on oilfield services, specialty chemicals, and midstream infrastructure, with an emphasis on solutions that reduce costs and improve operational efficiency. Black Bay is known for backing innovative companies like Advanced Industrial Devices and Capture Energy. The firm typically invests up to $30 million, favoring businesses with strong management teams and defensible competitive advantages. The firm's investment strategy prioritizes partnerships with entrepreneurs and is characterized by a thematic approach, leveraging its deep sector expertise. They prefer to lead rounds and often take control positions in their investments, although they remain flexible. Black Bay seeks companies with under $25 million EBITDA, ensuring scalable growth through operational improvements rather than financial engineering. Led by key figures such as Michael LeBourgeois and Matt Schovee, Black Bay is highly selective, only investing in businesses where it can add strategic value. Its geographic focus is primarily in the U.S., and the team actively supports its portfolio companies through technological investments and infrastructure development.

Black Diamond Ventures (BDV) is a Los Angeles-based venture capital firm founded in 1998 by Chris Lucas, with an additional office in Silicon Valley. Over more than two decades, the firm has built a track record of hybrid, multi-stage investing in biotech, deep tech, and medical technology. BDV's portfolio of 40 companies has generated 5 IPOs and 16 acquisitions — a realization rate that reflects the firm's discipline in identifying companies at genuine inflection points. BDV leads rounds from Series A through growth stages, typically writing checks between $3 million and $25 million. The firm invests across AI and machine learning, materials science, semiconductors, medical devices, and health technology. Notable portfolio outcomes include Dexcom, the continuous glucose monitoring company that grew into a multi-billion-dollar public market leader; GlobalLogic, the digital engineering firm acquired by Hitachi for $9.5 billion; and Avinger, which went public with vascular imaging technology. Other portfolio companies include Ares Materials, Lyric Bio, and App Orchid. Black Diamond Ventures supports visionary founders pioneering market-transforming technologies with strategic and operational guidance rooted in more than 25 years of company building. Chris Lucas and the BDV team bring deep domain familiarity in the scientific and technical disciplines at the core of their portfolio, allowing the firm to add substantive judgment beyond what generalist capital can offer. The firm's long operating history through multiple market cycles gives it the perspective and conviction required to back high-risk, high-impact technology bets.

Black Pearls VC is an early-stage venture capital firm based in Gdańsk, Poland, with a strategic focus on the Baltic Sea Region and Central Europe. They are particularly keen on deep tech startups developing unique, scalable technologies. The fund supports businesses from seed to Series A stages, with initial investments ranging from €100k to €1m and follow-on investments up to €3m. The firm has a sector-agnostic approach but has made significant strides in digital health, enterprise software, fintech, and deep tech. Notable portfolio companies include Nanoxo, a developer of non-toxic quantum dots for various industries; Xopero, specializing in data protection solutions; and Prosoma, which offers digital therapeutics for cancer patients​. Black Pearls VC's investment strategy emphasizes collaboration, often co-investing with other prominent funds. They focus on backing entrepreneurs with groundbreaking ideas and providing extensive support through their global network of advisors and partners. The team includes experts like Managing Partner Marcin P. Kowalik, who brings a wealth of experience in corporate finance and investment management. For startups looking to attract Black Pearls VC, it is essential to highlight the scalability and uniqueness of their technology. Approaching them through detailed pitches that align with their deep tech focus can significantly increase the chances of securing funding.

Blackhorn Ventures is an early-stage venture capital firm that focuses on investing in companies that drive industrial efficiency and environmental sustainability. The firm targets sectors such as energy, construction, supply chain logistics, and transportation. Some of the notable portfolio companies include Aperia, which develops tire inflation systems for trucks; Agorus, known for building custom homes quickly and precisely; and Electric Era, which creates advanced energy storage systems for EV charging stations. Blackhorn Ventures employs a capital-efficient approach, leveraging AI and digital solutions to modernize traditional industries and improve operational efficiency. The firm is deeply committed to decarbonizing industry sectors and aligning investments with environmental sustainability goals. The firm is led by experienced investors and operators who focus on creating value and engaging collaboratively with their portfolio companies and strategic partners to achieve both financial returns and impactful outcomes.

Blindspot Ventures is a seed-focused venture capital firm based in Boston, specializing in backing visionary founders who are reshaping industries through platform technologies and infrastructure innovation. The firm is known for partnering with bold, iconoclastic entrepreneurs who challenge the status quo and develop foundational technologies that drive industry evolution. Their portfolio includes cutting-edge companies like Form Energy, Mori, bloXroute, and Volta Labs, all of which are pioneers in fields ranging from renewable energy storage to advanced material science. Blindspot primarily invests in early-stage companies, with a typical check size of $500K to $3M. Their geographic focus is predominantly on the U.S., leveraging Boston’s rich history of innovation and proximity to top-tier academic institutions. Blindspot actively supports its portfolio companies, often taking board seats and offering strategic advice to foster long-term partnerships. Led by managing partners Ahmed Hentati and Hassan Dayekh, Blindspot is driven by a passion for addressing critical global challenges. Hentati, deeply ingrained in Boston’s startup ecosystem, focuses on identifying and backing groundbreaking founders, while Dayekh manages operations and co-leads the investment committee, bringing extensive experience from his background in banking and growth-stage venture capital.

Bling Capital is a venture capital firm specializing in seed-stage investments, founded by Ben Ling, who has a strong track record with 19 "unicorn" investments. The firm focuses on helping entrepreneurs achieve product-market fit and scale their businesses. Bling Capital has recently announced the closing of its third fund, raising $212 million, which includes a $109 million core seed fund and a $103 million opportunity fund to support companies as they grow. The firm's investment strategy targets sectors such as B2B software, consumer tech, digital health, fintech, and the future of work. Bling Capital typically invests around $1 million at the seed stage and provides extensive support through its Product Council, which comprises over 100 top product leaders from various industries. Notable companies in Bling Capital's portfolio include Lyft, Palantir, Lucidchart, Udemy, Gusto, and Instacart. The firm is dedicated to partnering with high-potential founders and supporting them through every stage of their journey.

Bloomberg Beta, an early-stage venture capital firm launched in 2013, manages $375 million in total across several funds. Backed solely by Bloomberg L.P., the firm focuses on investing in startups that aim to improve the future of work, emphasizing machine intelligence and data-centric technologies. Notable investments include companies such as Repl.it, a cloud computing platform for developers; LaunchDarkly, which helps software teams build better software faster; and StrongDM, an infrastructure access platform. Bloomberg Beta has also had significant exits, including Rigetti Computing, Orbital Insight, and Flashpoint​. The firm operates independently from Bloomberg L.P., and its team, led by Roy Bahat, Karin Klein, and James Cham, employs a unique investing model where any team member can independently approve deals. They maintain a strong commitment to transparency, with their operating manual and investment criteria publicly available on GitHub​​. Bloomberg Beta supports entrepreneurs through various stages of growth, leveraging data to identify potential founders and emphasizing a collaborative approach to investment. Their investment strategy is broad, focusing on startups that can bring transformative changes to how businesses operate and how people work

Blossom Capital, founded in 2017 and headquartered in London, has quickly established itself as a leading Series A investor in Europe. Led by Ophelia Brown, Imran Ghory, and Alex Lim, Blossom Capital focuses on high-potential sectors such as fintech, consumer internet, Web3, and enterprise SaaS. Notable investments include Moonpay, Checkout.com, Fat Llama, and Tines, demonstrating their knack for backing innovative startups. Blossom's strategy emphasizes deep, hands-on involvement, limiting investments to 5-6 Series A rounds per year to provide focused support. This approach includes assisting with recruitment, go-to-market strategies, and subsequent fundraising efforts. They prioritize building strong, long-term relationships with founders, often spending months getting to know them before committing to an investment​. The firm has a robust track record, with portfolio companies like Checkout.com and Moonpay achieving significant growth and valuations. Blossom's $432 million third fund, raised from prominent US and European investors, underscores their commitment to nurturing Europe's tech ecosystem​. For startups seeking to partner with Blossom, the key is demonstrating a clear vision and potential for substantial market impact. They value founders who are not only innovative but also resilient and prepared to scale efficiently. Blossom’s team, known for their rigorous support and strategic insight, is dedicated to propelling their portfolio companies to new heights.

Blue Bear Ventures (BBV) is a venture capital firm focused on deep tech innovations emerging from top research institutions, especially within the University of California system. Founded in 2017, BBV backs startups at the frontier of science and technology, particularly in areas like AI, synthetic biology, energy, and gene therapy. They work closely with founders who are often scientists and engineers, helping translate cutting-edge research into scalable businesses. The firm builds on its roots in the CITRIS Foundry accelerator at UC Berkeley, where it has nurtured groundbreaking startups. BBV typically invests in early-stage companies, emphasizing the impact of technology on sectors such as healthcare, energy infrastructure, and materials science. Some of their portfolio companies include Ayar Labs (optical data transmission), Clarity (air quality monitoring), and Coreshell (battery nanotechnology)​. BBV is committed to supporting deep tech entrepreneurs through a combination of financial investment and hands-on guidance, fostering startups that aim to solve global challenges.

Blue Horizon is a Zurich-based venture capital firm focused on investing in the future of food. Founded in 2016 by Bjoern Witte and Roger Lienhard, the firm has established itself as a leader in the sustainable food sector, managing over $850 million in assets and investing in more than 60 companies globally. The firm primarily targets the alternative protein and food technology industries, with notable investments in companies like Impossible Foods, Mosa Meat, and Planted. These investments reflect Blue Horizon's commitment to pioneering innovations that promote sustainability and environmental responsibility. Mosa Meat, for instance, developed the world’s first lab-grown beef burger, while Planted is a notable player in the vegan meat market. Blue Horizon’s investment strategy emphasizes a full lifecycle approach, supporting companies from seed stage through to significant growth phases. They focus on businesses that offer transformative solutions to global challenges in the food system, such as reducing reliance on traditional meat and dairy production, and promoting plant-based and cultured food alternatives. For startups looking to connect with Blue Horizon, demonstrating a strong alignment with their mission of creating a sustainable food system and showcasing innovative solutions that address significant market opportunities are key to forming a successful partnership.

Blue Ocean Partners, managed by SWEN Capital Partners, is a pioneering venture capital firm dedicated to restoring ocean health through impactful investments. Launched in 2021, Blue Ocean has quickly become the world’s largest ocean-focused venture fund, closing at €170 million in 2023, far exceeding its initial target of €120 million. The fund targets startups that are developing innovative solutions to combat key challenges facing the oceans, including overfishing, pollution, and climate change. The fund’s portfolio includes a diverse range of companies that are driving significant environmental impact. For example, ECOsubsea offers environmentally friendly in-water hull cleaning services that reduce carbon emissions and prevent the spread of invasive species. Another portfolio company, BlueNav, develops hybrid electric propulsion systems that help reduce the carbon footprint of marine transportation. Additionally, Avant is pioneering the production of cultivated seafood, offering a sustainable alternative to traditional fishing practices. Blue Ocean Partners is committed to generating both financial returns and measurable environmental outcomes. The fund’s investments are aligned with global efforts to regenerate marine ecosystems and contribute to the broader movement of sustainable ocean innovation. As a co-founder of the 1000 Ocean Start-ups initiative, Blue Ocean Partners plays a key role in scaling transformative ocean-focused technologies globally, further solidifying its leadership in the ocean impact investing space.

Blue Venture Fund (BVF) is the corporate venture capital arm of the Blue Cross Blue Shield Association, headquartered in Chicago, Illinois. Founded in 2008, BVF operates as a unique collaboration among 35 Blue Cross Blue Shield companies, the BCBS Association, and Sandbox Industries, which provides investment management services. Thirty-five BCBS companies have committed over $890 million across four funds, making it one of the largest healthcare-focused corporate venture platforms in the United States. Managing Directors include Tom Hawes and Jeff Carroll. BVF has made 149 investments and achieved 33 portfolio exits, investing in venture and growth opportunities in healthcare technology, healthcare services, and clinical sciences. Checks typically range from $3 million to $20 million across Series A through later stages. Portfolio companies include Big Health, Daymark Health, Alacura, Bluestone Physician Services, CirrusMD, Origin, and Nest Health. The most recent investment was Big Health's $23.7 million Series D in February 2026, alongside .406 Ventures, AlleyCorp, and CVS Health Ventures. Blue Venture Fund's strategic model connects portfolio companies directly to the knowledge, clinical expertise, and market access of 35 Blue Plan partners — a network covering a majority of insured Americans. For health technology companies seeking to prove commercial viability within the payer ecosystem, this access is structurally significant: it enables portfolio companies to conduct pilots, gather real-world evidence, and build distribution relationships with some of the largest healthcare purchasers in the country, accelerating both clinical validation and commercial scale.

Blue Wire Capital, established in 2013, is a London-based venture capital firm that focuses on early-stage investments, particularly in the pre-seed and seed stages. The firm invests across industries such as business software, environmental services, and educational technology. Notable portfolio companies include Climate X, Five, and Praktika.ai. Geographically, their investments are concentrated in Europe, with a strong presence in London. Blue Wire Capital's strategy emphasizes supporting visionary entrepreneurs addressing global challenges through technology. They typically lead investment rounds, with average check sizes around $5.96 million. They are active, engaging in 2-6 deals annually, and maintain a flexible approach to capital deployment. The team includes Bertie Highmore, Head of Investments, who brings experience from Goldman Sachs and Susquehanna International Group. To approach Blue Wire Capital, startups are advised to demonstrate innovative solutions with significant impact potential. The firm values fast and flexible access to capital, providing not just funding but also strategic support and networking opportunities to foster entrepreneurial success.